SARS-CoV-2 viral shedding and transmission dynamics: implications of WHO COVID-19 discharge guidelines

SOURCE: Frontiers in Medicine
OUTPUT TYPE: Journal Article
TITLE AUTHOR(S): K.Badu, K.Oyebola, J.Z.B.Zahouli, A.F.Fagbamigbe, D.K.De Souza, N.Dukhi, E.F.Amankwaa, M.F.Tolba, A.A.Sylverken, L.Mosi, P.K.Mante, D.Matoke-Muhia, N.Goonoo
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 12098
HANDLE: 20.500.11910/16377

Download this report

If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at


The evolving nature of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has necessitated periodic revisions of COVID-19 patient treatment and discharge guidelines. Since the identification of the first COVID-19 cases in November 2019, the World Health Organization (WHO) has played a crucial role in tackling the country-level pandemic preparedness and patient management protocols. Among others, the WHO provided a guideline on the clinical management of COVID-19 patients according to which patients can be released from isolation centers on the 10th day following clinical symptom manifestation, with a minimum of 72 additional hours following the resolution of symptoms. However, emerging direct evidence indicating the possibility of viral shedding 14 days after the onset of symptoms called for evaluation of the current WHO discharge recommendations. In this review article, we carried out comprehensive literature analysis of viral shedding with specific focus on the duration of viral shedding and infectivity in asymptomatic and symptomatic (mild, moderate, and severe forms) COVID-19 patients. Our literature search indicates that even though, there are specific instances where the current protocols may not be applicable (such as in immune compromised patients there is no strong evidence to contradict the current WHO discharge criteria.